Hepatic tissue engineering.

Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11

Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49

Silk fibroin/chitosan scaffold: preparation, characterization, and culture with HepG2 cell. J Mater Sci Mater Med (2008) 0.98

Liver bioengineering: current status and future perspectives. World J Gastroenterol (2012) 0.95

Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem Cell Res Ther (2013) 0.92

Decellularization and recellularization of whole livers. J Vis Exp (2011) 0.89

Application of whole-organ tissue engineering in hepatology. Nat Rev Gastroenterol Hepatol (2012) 0.89

Preparation and characterization of chitosan/galactosylated hyaluronic acid scaffolds for primary hepatocytes culture. J Mater Sci Mater Med (2009) 0.88

Multilayer nanofilms as substrates for hepatocellular applications. Biomaterials (2008) 0.83

Titanium Dioxide Nanoparticles Trigger Loss of Function and Perturbation of Mitochondrial Dynamics in Primary Hepatocytes. PLoS One (2015) 0.79

Engineered liver for transplantation. Curr Opin Biotechnol (2013) 0.79

Hepatic tissue engineering using scaffolds: state of the art. Avicenna J Med Biotechnol (2009) 0.78

Poly(lactic-co-glycolic) acid/nanohydroxyapatite scaffold containing chitosan microspheres with adrenomedullin delivery for modulation activity of osteoblasts and vascular endothelial cells. Biomed Res Int (2013) 0.78

Improvement of mesenchymal stem cell differentiation into the endoderm lineage by four step sequential method in biocompatible biomaterial. Bioimpacts (2016) 0.78

Poly(vinyl alcohol)/gelatin Hydrogels Cultured with HepG2 Cells as a 3D Model of Hepatocellular Carcinoma: A Morphological Study. J Funct Biomater (2015) 0.77

Immunoblot analysis of proteins associated with self-assembled monolayer surfaces of defined chemistries. J Biomed Mater Res A (2011) 0.77

Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine. Protein Cell (2015) 0.76

Manipulating the microvasculature and its microenvironment. Crit Rev Biomed Eng (2013) 0.76

Use an alginate scaffold-bone marrow stromal cell (BMSC) complex for the treatment of acute liver failure in rats. Int J Clin Exp Med (2015) 0.75

Bioengineering the gut: future prospects of regenerative medicine. Nat Rev Gastroenterol Hepatol (2016) 0.75

Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering. J Biomater Appl (2012) 0.75

Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66

Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59

Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med (2013) 5.36

Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23

Progress in tissue engineering. Sci Am (2009) 2.08

Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices (2004) 1.97

Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93

Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg (2011) 1.75

Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg (2004) 1.64

Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49

Microfabrication of three-dimensional engineered scaffolds. Tissue Eng (2007) 1.48

Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47

Tissue-engineered hybrid tooth and bone. Tissue Eng (2005) 1.46

In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng (2004) 1.34

Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone (2005) 1.20

The tissue-engineered auricle: past, present, and future. Tissue Eng Part B Rev (2011) 1.20

Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18

Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation (2002) 1.17

Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials (2004) 1.17

Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg (2003) 1.17

Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res (2002) 1.15

Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15

Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg (2004) 1.13

Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip (2010) 1.13

Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg (2003) 1.08

The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07

Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg (2006) 1.03

Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg (2003) 1.01

Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol (2003) 1.01

Engineering extracellular matrix through nanotechnology. J R Soc Interface (2010) 1.00

The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials (2010) 1.00

Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev (2009) 1.00

Engineering ear constructs with a composite scaffold to maintain dimensions. Tissue Eng Part A (2011) 0.99

Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res (2008) 0.98

Prospects for tooth regeneration. Periodontol 2000 (2006) 0.98

Toward regenerating a human thumb in situ. Tissue Eng Part A (2009) 0.97

Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96

Bioengineered teeth from tooth bud cells. Dent Clin North Am (2006) 0.95

Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res (2002) 0.95

Tissue-engineered small intestine: ontogeny of the immune system. Transplantation (2002) 0.94

Reconstructing mandibular defects using autologous tissue-engineered tooth and bone constructs. J Oral Maxillofac Surg (2009) 0.94

The need for tolerance in pediatric organ transplantation. Pediatrics (2008) 0.92

Effect of implantation site on hepatocytes heterotopically transplanted on biodegradable polymer scaffolds. Tissue Eng (2003) 0.92

Tissue engineered hybrid tooth-bone constructs. Methods (2008) 0.91

State-of-the-art tissue engineering: from tissue engineering to organ building. Surgery (2005) 0.91

Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. Biomaterials (2010) 0.91

Principles of biomimetic vascular network design applied to a tissue-engineered liver scaffold. Tissue Eng Part A (2010) 0.89

Tissue-engineered colon exhibits function in vivo. Surgery (2002) 0.89

In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J Thorac Cardiovasc Surg (2005) 0.88

Tissue-engineered stomach: a preliminary report of a versatile in vivo model with therapeutic potential. J Pediatr Surg (2003) 0.88

Lymphangiogenesis in tissue-engineered small intestine. Transplantation (2004) 0.88

Liver-assist device with a microfluidics-based vascular bed in an animal model. Ann Surg (2010) 0.88

Angiogenesis in tissue-engineered small intestine. Tissue Eng (2003) 0.88

A tissue-engineered stomach as a replacement of the native stomach. Transplantation (2003) 0.88

The generation of functionally differentiated, three-dimensional hepatic tissue from two-dimensional sheets of progenitor small hepatocytes and nonparenchymal cells. Transplantation (2004) 0.87

Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg (2003) 0.87

Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells (2005) 0.86

Nanofabricated collagen-inspired synthetic elastomers for primary rat hepatocyte culture. Tissue Eng Part A (2009) 0.86

Effect of ibuprofen on osteoblast differentiation of porcine bone marrow-derived progenitor cells. J Oral Maxillofac Surg (2009) 0.86

Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery (2006) 0.86

Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography. Transplantation (2003) 0.86

An overview of the pathology and approaches to tissue engineering. Ann N Y Acad Sci (2002) 0.85

Hydrogel optimization for cultured elastic chondrocytes seeded onto a polyglycolic acid scaffold. J Biomed Mater Res A (2005) 0.85

The engineering of craniofacial tissues in the laboratory: a review of biomaterials for scaffolds and implant coatings. Dent Clin North Am (2006) 0.85

Successful creation of tissue-engineered autologous auricular cartilage in an immunocompetent large animal model. Tissue Eng Part A (2013) 0.84

Osteoclastogenesis on tissue-engineered bone. Tissue Eng (2004) 0.84

Design of composite scaffolds and three-dimensional shape analysis for tissue-engineered ear. J R Soc Interface (2013) 0.84

Fetal tissue engineering: in utero tracheal augmentation in an ovine model. J Pediatr Surg (2002) 0.84

Comparison of hydrogels in the in vivo formation of tissue-engineered bone using mesenchymal stem cells and beta-tricalcium phosphate. Tissue Eng (2007) 0.83

Toward a new blood vessel. Vasc Med (2002) 0.83

A novel tissue engineering approach using an endothelial progenitor cell-seeded biopolymer to treat intracranial saccular aneurysms. J Neurosurg (2012) 0.82

Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. Int J Artif Organs (2009) 0.81

Fetal tissue engineering: in vitro analysis of muscle constructs. J Pediatr Surg (2003) 0.80

Development of a biodegradable scaffold with interconnected pores by heat fusion and its application to bone tissue engineering. J Biomed Mater Res A (2008) 0.80

Biologic activity of nerve growth factor slowly released from microspheres. J Reconstr Microsurg (2003) 0.80

The history and current status of tissue engineering: The future of pediatric surgery. J Pediatr Surg (2002) 0.80

In vitro cartilage regeneration from proliferated adult elastic chondrocytes. Ann Plast Surg (2005) 0.80

Three-dimensionally printed polycaprolactone and β-tricalcium phosphate scaffolds for bone tissue engineering: an in vitro study. J Oral Maxillofac Surg (2011) 0.80

Branched vascular network architecture: a new approach to lung assist device technology. J Thorac Cardiovasc Surg (2010) 0.79

Tissue-engineered spleen protects against overwhelming pneumococcal sepsis in a rodent model. J Surg Res (2008) 0.79

Growth factor directed chondrogenic differentiation of porcine bone marrow-derived progenitor cells. J Craniofac Surg (2013) 0.78

Biologic properties of surgical scaffold materials derived from dermal ECM. Biomaterials (2013) 0.78

A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng (2002) 0.78

Ultra-thin, gas permeable free-standing and composite membranes for microfluidic lung assist devices. Biomaterials (2011) 0.78

Engineered fetal cartilage: structural and functional analysis in vitro. J Pediatr Surg (2002) 0.78

Effect of interferon-alpha-2b on porcine mesenchymal stem cells. J Oral Maxillofac Surg (2006) 0.78

Influence of vascular network design on gas transfer in lung assist device technology. ASAIO J (2011) 0.78

Human shaped thumb bone tissue engineered by hydrogel-beta-tricalciumphosphate/poly-epsilon-caprolactone scaffolds and magnetically sorted stem cells. Ann Plast Surg (2007) 0.77

Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells. J Heart Lung Transplant (2005) 0.77

Mechanical dissociation of swine liver to produce organoid units for tissue engineering and in vitro disease modeling. Artif Organs (2010) 0.76

The promise of artificial liver replacement. Front Biosci (2008) 0.76

Assessing emerging technologies--the case of organ replacement technologies: volume, durability, cost. Int J Technol Assess Health Care (2007) 0.75

Optimizing Biomaterials for Tissue Engineering Human Bone Using Mesenchymal Stem Cells. Plast Reconstr Surg (2016) 0.75

Tissue engineering in the 21st century. Surg Technol Int (2002) 0.75

Poly(glycerol sebacate) films prevent postoperative adhesions and allow laparoscopic placement. Surgery (2009) 0.75

Editorial: tissue engineering: a 20-year personal perspective. Tissue Eng (2007) 0.75

Fetal tissue engineering: chest wall reconstruction. J Pediatr Surg (2003) 0.75

Ovine model for auricular reconstruction: porous polyethylene implants. Ann Otol Rhinol Laryngol (2014) 0.75

Initial assessment of a tissue engineered stomach derived from syngeneic donors in a rat model. ASAIO J (2004) 0.75